Shopping Cart

Call us free: +44-800-193-0027

Free UK shipping on all orders over £50

UK prescription cannabis recalled for containing toxic mould

© iStock-tvirbickis

UK prescription cannabis supplier NOIDECS has recalled two batches of product and has advised patients not to use their prescription medicine after reports of mould toxicity.

This week Cancard – the UK’s new medical cannabis ID card – that represents 27,000 patients in the UK received numerous reports of patients suffering from mould toxicity induced by their legal supply of medicinal cannabis flower which had been provided by NOIDECS.

Both NOIDECS and the UK Government have released statements recalling two batches of product and advising patients not to use their prescription medicine.

The Government website states: ‘The importer and distributor of the above products (Eaststone Limited) has informed us of reports that two affected batches may be contaminated with mould. Therefore, these batches are being recalled as a precautionary measure. This recall is being issued as a company-led recall due to the limited number of packs distributed, and Eaststone Limited have full traceability of the onward distribution by their customers.’

Inhaling mould can cause severe headaches, lung dysfunction, immune reactions, and asthma attacks.

Contaminated products

The two products that have been identified as having toxic mould contamination are Noidecs T20/C4 (THC 20%; CBD <4%) Indica Cannabis Flower and Noidecs T20/C4 (THC 20%; CBD <4%) Sativa Cannabis Flower.

Carly Barton of Cancard said: “This is such a disappointing situation. Many patients in the UK have spent thousands of pounds to become legally protected from prosecution for taking the medicine that helps them, they do so in the belief that these products would be safer. The fact that patients who live with chronic debilitating illnesses are now suffering from mould toxicity simply for choosing the legal route is unforgivable.

“Realistically small grow operations that are currently illegal in the UK have better quality control, this is difficult with large scale operations where the required care and attention isn’t as viable. Many patients have returned to the illicit market this weekend and have lost faith in the private clinics. This is the result of a profit-driven model. There is space for a more community cantered approach – with a health centre and dispensary that comes from a more genuine place with rigorous testing.”

A patient who had used a contaminated product said: “These headaches are so bad, this is supposed to be medicine, but it has made me sick. What am I going to do now? How can I trust the next batch? I have been taking cannabis for 30 years, I have never gotten mouldy product from my dealers.”




Subscribe to our newsletter






Source link

Leave a Reply

Your email address will not be published. Required fields are marked *